{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:16:52Z","timestamp":1775024212151,"version":"3.50.1"},"reference-count":15,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2021,11,22]]},"DOI":"10.7883\/yoken.jjid.2020.1019","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T22:10:32Z","timestamp":1617142232000},"page":"567-569","source":"Crossref","is-referenced-by-count":5,"title":["Quantitative Investigation of Viral Load in Acute to Subacute Human Adenovirus Type 54 Conjunctivitis"],"prefix":"10.7883","volume":"74","author":[{"given":"Kazuki","family":"Matsuura","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Nojima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Terasaka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Nojima Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitsugu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology and Visual Science, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matsuura K, Terasaka Y, Miyazaki D, et al. Comparative study of topical regimen for adenoviral kearoconjunctivitis by 0.1% fluorometholone with and without polyvinyl alcohol iodine. Jpn J Ophthalmol. 2021;65:107-14.","DOI":"10.1007\/s10384-020-00788-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Takeuchi S, Itoh N, Uchio E, et al. Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis. J Clin Microbiol. 1999;37:1839-45.","DOI":"10.1128\/JCM.37.6.1839-1845.1999"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fujimoto T, Matsushima Y, Shimizu H, et al. A molecular epidemiologic study of human adenovirus type 8 isolates causing epidemic keratoconjunctivitis in Kawasaki City, Japan in 2011. Jpn J Infect Dis. 2012;65:260-3.","DOI":"10.7883\/yoken.65.260"},{"key":"4","unstructured":"4. Inoue Y. Treatment of viral conjunctivitis. Nippon Ganka Gakkai Zasshi. 2003; 107:24-6. Japanese."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Romanowski EG, Yates KA, Gordon YJ. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5\/NZW rabbit ocular model. Cornea. 2002;21:289-91.","DOI":"10.1097\/00003226-200204000-00010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kawana R, Kitamura T, Nakagomi O, et al. Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology. 1997;195 Suppl 2:29-35.","DOI":"10.1159\/000246027"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pepose JS, Ahuja A, Liu W, et al. Randomized, controlled, phase 2 trial of povidone-iodine\/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7-15.","DOI":"10.1016\/j.ajo.2018.05.012"},{"key":"8","unstructured":"8. Yazar H, Yarbag A, Balci M, et al. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis. J Pak Med Assoc. 2016;66:968-70."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Clement C, Capriotti JA, Kumar M, et al. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Invest Ophthalmol Vis Sci. 2011;52:339-44.","DOI":"10.1167\/iovs.10-5944"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pelletier JS, Stewart K, Trattler W, et al. A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009;26:776-83.","DOI":"10.1007\/s12325-009-0062-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Pinto RD, Lira RP, Abe RY, et al. Dexamethasone\/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial. Curr Eye Res. 2015;40:870-7.","DOI":"10.3109\/02713683.2014.964419"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pepose JS, Narvekar A, Liu W, et al. A randomized controlled trial of povidone-iodine\/dexamethasone ophthalmic suspension for acute viral conjunctivitis. Clin Ophthalmol. 2019;13:535-44.","DOI":"10.2147\/OPTH.S191275"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Isenberg SJ, Apt L, Valenton M, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681-8.","DOI":"10.1016\/S0002-9394(02)01701-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kimura R, Migita H, Kadonosono K, et al. Is it possible to detect the presence of adenovirus in conjunctiva before the onset of conjunctivitis? Acta Ophthalmol. 2009;87:44-7.","DOI":"10.1111\/j.1755-3768.2007.01148.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kaneko H, Maruko I, Iida T, et al. The possibility of human adenovirus detection from the conjunctiva in asymptomatic cases during nosocomial infection. Cornea. 2008;27:527-30.","DOI":"10.1097\/ICO.0b013e31816060bb"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/6\/74_JJID.2020.1019\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T03:51:34Z","timestamp":1637985094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/74\/6\/74_JJID.2020.1019\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2020.1019","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"article-number":"JJID.2020.1019"}}